Cargando…
Ending hepatitis C in the United States: the role of screening
The US faces at least two distinct epidemics of hepatitis C virus infection (HCV), and due largely to revised screening recommendations and novel therapeutic agents, corresponding opportunities. As only 49%–75% of HCV-infected persons in the US are aware of their infection, any chance of addressing...
Autores principales: | Coffin, Phillip O, Reynolds, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086667/ https://www.ncbi.nlm.nih.gov/pubmed/25114602 http://dx.doi.org/10.2147/HMER.S40940 |
Ejemplares similares
-
Patient acceptance of universal screening for hepatitis C virus infection
por: Coffin, Phillip O, et al.
Publicado: (2011) -
Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States
por: Tatar, Moosa, et al.
Publicado: (2020) -
CDC Recommendations for Hepatitis C Screening Among Adults — United States, 2020
por: Schillie, Sarah, et al.
Publicado: (2020) -
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023
por: Conners, Erin E., et al.
Publicado: (2023) -
COVID‐19 and the Uncovering of Health Care Disparities in the United States, United Kingdom and Canada: Call to Action
por: Ala, Aftab, et al.
Publicado: (2021)